There is quite a lot of newsflow to look forward to including MC licence, potential acquisition, national retailer distribution agreement, strong quarterly on the back of Black Friday sales. More global sales agreements and opening up of more countries to the Elixinol branded product sales.
I reckon $14m revenue would be a monster quarter..it would represent accelerating momentum and quarter on quarter growth rates of 35%.
They do have a little currency advantage with majority of sales in USD buy that was also the case the last couple of quarters..
Share price is really starting to reflect the true potential of this company..
Top 5 in hemp derived CBD market, page-117
-
- There are more pages in this discussion • 157 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.605M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.605K | 321.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 6265944 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 14532474 | 10 |
View Market Depth
| Last trade - 15.57pm 25/11/2024 (20 minute delay) ? |
| EXL (ASX) Chart |
